BioSpace News Archive

Press Releases

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

December 3, 2024
·
8 min read
Press Releases

Martin Pharmaceuticals Secures Exclusive Rights From Mitsubishi Tanabe Pharma for Docarpamine to Treat Decompensated Chronic Liver Disease Including Ascites

December 3, 2024
·
4 min read
Press Releases

Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

December 3, 2024
·
1 min read
Press Releases

Enpro to Present at the Sidoti December Small Cap Conference

December 3, 2024
·
1 min read
Press Releases

Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects

December 3, 2024
·
5 min read
Press Releases

PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET

December 3, 2024
·
7 min read
Press Releases

Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

December 3, 2024
·
10 min read
Press Releases

Artificial Intelligence in Diagnostics Market Size to Hit USD 8.54 Bn by 2033

December 3, 2024
·
1 min read
Press Releases

Kane Biotech Announces $3,000,000 Private Placement Offering

December 3, 2024
·
3 min read
Press Releases

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

December 3, 2024
·
6 min read